SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '5c65'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1FAP_A_RAPA108_2 (FK506-BINDING PROTEIN FRAP)	5c65	SOLUTE CARRIER FAMILY 2, FACILITATED GLUCOSE TRANSPORTER MEMBER 3 (Homo sapiens)	4 / 8	SER A 146 ARG A 151 PHE A 154 GLY A 152	None	0.87A	1fapB-5c65A: 2.1	1fapB-5c65A: 11.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1FBM_B_RTLB951_0 (PROTEIN (CARTILAGE OLIGOMERIC MATRIX PROTEIN))	5c65	SOLUTE CARRIER FAMILY 2, FACILITATED GLUCOSE TRANSPORTER MEMBER 3 (Homo sapiens)	4 / 4	THR A 156 LEU A 160 LEU A 167 GLN A 170	None	1.03A	1fbmA-5c65A: undetectable	1fbmA-5c65A: 7.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1MZ9_D_VDYD1001_4 (CARTILAGE OLIGOMERIC MATRIX PROTEIN)	5c65	SOLUTE CARRIER FAMILY 2, FACILITATED GLUCOSE TRANSPORTER MEMBER 3 (Homo sapiens)	4 / 4	THR A 156 LEU A 160 VAL A 163 LEU A 167	None	0.73A	1mz9D-5c65A: undetectable	1mz9D-5c65A: 7.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1Y0X_X_T44X500_1 (THYROID HORMONE RECEPTOR BETA-1)	5c65	SOLUTE CARRIER FAMILY 2, FACILITATED GLUCOSE TRANSPORTER MEMBER 3 (Homo sapiens)	5 / 12	ILE A 14 ALA A 17 LEU A 229 ILE A 225 PHE A 154	None	1.26A	1y0xX-5c65A: undetectable	1y0xX-5c65A: 20.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2J7X_A_ESTA1454_1 (ESTROGEN RECEPTOR BETA)	5c65	SOLUTE CARRIER FAMILY 2, FACILITATED GLUCOSE TRANSPORTER MEMBER 3 (Homo sapiens)	5 / 12	LEU A 276 LEU A 339 ILE A 285 GLY A 284 LEU A 282	None	1.24A	2j7xA-5c65A: undetectable	2j7xA-5c65A: 21.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2J9D_J_ACTJ1116_0 (HYPOTHETICAL NITROGEN REGULATORY PII-LIKE PROTEIN MJ0059)	5c65	SOLUTE CARRIER FAMILY 2, FACILITATED GLUCOSE TRANSPORTER MEMBER 3 (Homo sapiens)	4 / 8	GLU A 391 ILE A 388 ILE A 384 GLU A 452	None	0.90A	2j9dJ-5c65A: undetectable 2j9dK-5c65A: undetectable 2j9dL-5c65A: undetectable	2j9dJ-5c65A: 13.51 2j9dK-5c65A: 13.51 2j9dL-5c65A: 13.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2NYR_B_SVRB401_2 (NAD-DEPENDENT DEACETYLASE SIRTUIN-5)	5c65	SOLUTE CARRIER FAMILY 2, FACILITATED GLUCOSE TRANSPORTER MEMBER 3 (Homo sapiens)	4 / 6	PHE A 414 GLN A 281 ASN A 409 LEU A 439	None	1.26A	2nyrA-5c65A: undetectable	2nyrA-5c65A: 21.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2P2F_A_ACTA653_0 (ACETYL-COENZYME A SYNTHETASE)	5c65	SOLUTE CARRIER FAMILY 2, FACILITATED GLUCOSE TRANSPORTER MEMBER 3 (Homo sapiens)	4 / 5	VAL A 320 THR A 319 VAL A 163 GLY A 161	None	1.00A	2p2fA-5c65A: undetectable	2p2fA-5c65A: 22.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2P2F_B_ACTB653_0 (ACETYL-COENZYME A SYNTHETASE)	5c65	SOLUTE CARRIER FAMILY 2, FACILITATED GLUCOSE TRANSPORTER MEMBER 3 (Homo sapiens)	4 / 4	VAL A 320 THR A 319 VAL A 163 GLY A 161	None	0.98A	2p2fB-5c65A: undetectable	2p2fB-5c65A: 22.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2W3B_B_FOLB401_1 (DIHYDROFOLATE REDUCTASE)	5c65	SOLUTE CARRIER FAMILY 2, FACILITATED GLUCOSE TRANSPORTER MEMBER 3 (Homo sapiens)	3 / 3	GLU A 252 GLN A 395 ARG A 398	None	0.97A	2w3bB-5c65A: undetectable	2w3bB-5c65A: 16.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2XCT_X_CPFX1020_1 (DNA GYRASE SUBUNIT B, DNA GYRASE SUBUNIT A)	5c65	SOLUTE CARRIER FAMILY 2, FACILITATED GLUCOSE TRANSPORTER MEMBER 3 (Homo sapiens)	4 / 4	ARG A 248 GLY A 396 GLU A 252 SER A 208	None	1.11A	2xctS-5c65A: undetectable 2xctU-5c65A: undetectable	2xctS-5c65A: 20.58 2xctU-5c65A: 20.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2XRH_A_NIOA200_1 (PROTEIN HP0721)	5c65	SOLUTE CARRIER FAMILY 2, FACILITATED GLUCOSE TRANSPORTER MEMBER 3 (Homo sapiens)	4 / 7	GLY A 161 ILE A 166 THR A 28 GLN A 159	None	0.98A	2xrhA-5c65A: undetectable	2xrhA-5c65A: 10.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AG2_W_CHDW1059_0 (CYTOCHROME C OXIDASE POLYPEPTIDE 7A1 CYTOCHROME C OXIDASE SUBUNIT 1)	5c65	SOLUTE CARRIER FAMILY 2, FACILITATED GLUCOSE TRANSPORTER MEMBER 3 (Homo sapiens)	4 / 7	ILE A 388 PHE A 387 ARG A 454 THR A 333	None	0.98A	3ag2N-5c65A: undetectable 3ag2W-5c65A: undetectable	3ag2N-5c65A: 24.43 3ag2W-5c65A: 9.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AG4_W_CHDW1059_0 (CYTOCHROME C OXIDASE POLYPEPTIDE 7A1 CYTOCHROME C OXIDASE SUBUNIT 1)	5c65	SOLUTE CARRIER FAMILY 2, FACILITATED GLUCOSE TRANSPORTER MEMBER 3 (Homo sapiens)	4 / 7	ILE A 388 PHE A 387 ARG A 454 THR A 333	None	0.95A	3ag4N-5c65A: undetectable 3ag4W-5c65A: undetectable	3ag4N-5c65A: 24.43 3ag4W-5c65A: 9.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3BOG_D_DVAD47_0 (6.5 KDA GLYCINE-RICH ANTIFREEZE PROTEIN)	5c65	SOLUTE CARRIER FAMILY 2, FACILITATED GLUCOSE TRANSPORTER MEMBER 3 (Homo sapiens)	4 / 4	GLY A 77 GLY A 74 GLY A 128 GLY A 132	None	0.64A	3bogD-5c65A: undetectable	3bogD-5c65A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DH0_A_SAMA220_0 (SAM DEPENDENT METHYLTRANSFERASE)	5c65	SOLUTE CARRIER FAMILY 2, FACILITATED GLUCOSE TRANSPORTER MEMBER 3 (Homo sapiens)	5 / 12	LEU A 133 VAL A 72 GLY A 73 GLY A 77 PHE A 130	None	1.36A	3dh0A-5c65A: undetectable	3dh0A-5c65A: 17.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3RQW_C_ACHC323_0 (ELIC PENTAMERIC LIGAND GATED ION CHANNEL FROM ERWINIA CHRYSANTHEMI)	5c65	SOLUTE CARRIER FAMILY 2, FACILITATED GLUCOSE TRANSPORTER MEMBER 3 (Homo sapiens)	4 / 8	PHE A 393 GLU A 252 TYR A 266 LEU A 260	None	0.95A	3rqwC-5c65A: 1.7 3rqwD-5c65A: 1.7	3rqwC-5c65A: 21.57 3rqwD-5c65A: 21.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3RQW_I_ACHI323_0 (ELIC PENTAMERIC LIGAND GATED ION CHANNEL FROM ERWINIA CHRYSANTHEMI)	5c65	SOLUTE CARRIER FAMILY 2, FACILITATED GLUCOSE TRANSPORTER MEMBER 3 (Homo sapiens)	4 / 8	PHE A 393 GLU A 252 TYR A 266 LEU A 260	None	0.97A	3rqwI-5c65A: undetectable 3rqwJ-5c65A: undetectable	3rqwI-5c65A: 21.57 3rqwJ-5c65A: 21.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3RQW_J_ACHJ323_0 (ELIC PENTAMERIC LIGAND GATED ION CHANNEL FROM ERWINIA CHRYSANTHEMI)	5c65	SOLUTE CARRIER FAMILY 2, FACILITATED GLUCOSE TRANSPORTER MEMBER 3 (Homo sapiens)	4 / 8	GLU A 252 TYR A 266 LEU A 260 PHE A 393	None	1.01A	3rqwF-5c65A: undetectable 3rqwJ-5c65A: undetectable	3rqwF-5c65A: 21.57 3rqwJ-5c65A: 21.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4FR0_A_SAMA401_0 (ARSENIC METHYLTRANSFERASE)	5c65	SOLUTE CARRIER FAMILY 2, FACILITATED GLUCOSE TRANSPORTER MEMBER 3 (Homo sapiens)	5 / 12	GLY A 152 GLY A 155 GLU A 452 VAL A 326 LEU A 334	None	1.10A	4fr0A-5c65A: undetectable	4fr0A-5c65A: 22.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4J26_A_ESTA600_1 (ESTROGEN RECEPTOR BETA)	5c65	SOLUTE CARRIER FAMILY 2, FACILITATED GLUCOSE TRANSPORTER MEMBER 3 (Homo sapiens)	5 / 12	LEU A 276 LEU A 339 ILE A 285 GLY A 284 LEU A 282	None	1.28A	4j26A-5c65A: undetectable	4j26A-5c65A: 21.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4OBW_B_SAMB601_0 (2-METHOXY-6-POLYPREN YL-1,4-BENZOQUINOL METHYLASE, MITOCHONDRIAL)	5c65	SOLUTE CARRIER FAMILY 2, FACILITATED GLUCOSE TRANSPORTER MEMBER 3 (Homo sapiens)	5 / 12	ASN A 413 GLY A 73 GLY A 74 ILE A 127 GLY A 123	None	1.01A	4obwB-5c65A: undetectable	4obwB-5c65A: 19.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4Z3O_F_MFXF101_1 (DNA TOPOISOMERASE 4 SUBUNIT B,PARE30-PARC55 FUSED TOPO IV FROM S. PNEUMONIAE E-SITE DNA)	5c65	SOLUTE CARRIER FAMILY 2, FACILITATED GLUCOSE TRANSPORTER MEMBER 3 (Homo sapiens)	4 / 5	ARG A 248 GLY A 396 GLU A 252 SER A 208	None	1.08A	4z3oA-5c65A: undetectable 4z3oB-5c65A: undetectable	4z3oA-5c65A: 22.10 4z3oB-5c65A: 22.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5B1A_W_CHDW101_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	5c65	SOLUTE CARRIER FAMILY 2, FACILITATED GLUCOSE TRANSPORTER MEMBER 3 (Homo sapiens)	4 / 6	ILE A 388 PHE A 387 ARG A 454 THR A 333	None	1.04A	5b1aN-5c65A: 0.7 5b1aW-5c65A: undetectable	5b1aN-5c65A: 24.43 5b1aW-5c65A: 9.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5B3S_W_CHDW101_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	5c65	SOLUTE CARRIER FAMILY 2, FACILITATED GLUCOSE TRANSPORTER MEMBER 3 (Homo sapiens)	4 / 7	ILE A 388 PHE A 387 ARG A 454 THR A 333	None	0.91A	5b3sN-5c65A: 0.3 5b3sW-5c65A: undetectable	5b3sN-5c65A: 24.43 5b3sW-5c65A: 9.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5CDQ_E_MFXE2101_1 (DNA GYRASE SUBUNIT A DNA GYRASE SUBUNIT B,DNA GYRASE SUBUNIT B)	5c65	SOLUTE CARRIER FAMILY 2, FACILITATED GLUCOSE TRANSPORTER MEMBER 3 (Homo sapiens)	4 / 5	SER A 208 ARG A 248 GLY A 396 GLU A 252	None	0.88A	5cdqA-5c65A: 1.3 5cdqB-5c65A: undetectable 5cdqC-5c65A: 1.3	5cdqA-5c65A: 22.54 5cdqB-5c65A: 16.77 5cdqC-5c65A: 22.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5CDQ_V_MFXV2101_1 (DNA GYRASE SUBUNIT A DNA GYRASE SUBUNIT B,DNA GYRASE SUBUNIT B)	5c65	SOLUTE CARRIER FAMILY 2, FACILITATED GLUCOSE TRANSPORTER MEMBER 3 (Homo sapiens)	4 / 5	SER A 208 ARG A 248 GLY A 396 GLU A 252	None	0.89A	5cdqR-5c65A: 1.3 5cdqS-5c65A: undetectable 5cdqT-5c65A: undetectable	5cdqR-5c65A: 22.54 5cdqS-5c65A: 16.77 5cdqT-5c65A: 22.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5EQB_A_1YNA602_1 (LANOSTEROL 14-ALPHA DEMETHYLASE)	5c65	SOLUTE CARRIER FAMILY 2, FACILITATED GLUCOSE TRANSPORTER MEMBER 3 (Homo sapiens)	5 / 12	GLY A 380 PHE A 70 PHE A 24 GLY A 128 GLY A 132	None	0.92A	5eqbA-5c65A: undetectable	5eqbA-5c65A: 23.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ODI_A_ACTA701_0 (HETERODISULFIDE REDUCTASE, SUBUNIT A)	5c65	SOLUTE CARRIER FAMILY 2, FACILITATED GLUCOSE TRANSPORTER MEMBER 3 (Homo sapiens)	3 / 3	LYS A 217 LYS A 243 SER A 246	None	1.35A	5odiA-5c65A: undetectable	5odiA-5c65A: 19.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5XDX_W_CHDW101_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT VIIA-HEART)	5c65	SOLUTE CARRIER FAMILY 2, FACILITATED GLUCOSE TRANSPORTER MEMBER 3 (Homo sapiens)	4 / 8	ILE A 388 PHE A 387 ARG A 454 THR A 333	None	0.91A	5xdxN-5c65A: 0.6 5xdxW-5c65A: undetectable	5xdxN-5c65A: 24.43 5xdxW-5c65A: 9.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5Z84_W_CHDW101_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	5c65	SOLUTE CARRIER FAMILY 2, FACILITATED GLUCOSE TRANSPORTER MEMBER 3 (Homo sapiens)	4 / 5	ILE A 388 PHE A 387 ARG A 454 THR A 333	None	0.93A	5z84N-5c65A: 0.6 5z84W-5c65A: undetectable	5z84N-5c65A: 24.43 5z84W-5c65A: 9.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6CDU_A_EY4A501_0 (CHIMERIC ALPHA1GABAA RECEPTOR)	5c65	SOLUTE CARRIER FAMILY 2, FACILITATED GLUCOSE TRANSPORTER MEMBER 3 (Homo sapiens)	4 / 5	GLN A 277 VAL A 275 PRO A 385 THR A 441	None	1.47A	6cduA-5c65A: 2.2 6cduB-5c65A: 1.8	6cduA-5c65A: 21.24 6cduB-5c65A: 21.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6CDU_I_EY4I500_0 (CHIMERIC ALPHA1GABAA RECEPTOR)	5c65	SOLUTE CARRIER FAMILY 2, FACILITATED GLUCOSE TRANSPORTER MEMBER 3 (Homo sapiens)	4 / 5	GLN A 277 VAL A 275 PRO A 385 THR A 441	None	1.50A	6cduI-5c65A: 1.8 6cduJ-5c65A: 1.6	6cduI-5c65A: 21.24 6cduJ-5c65A: 21.24

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1FAP_A_RAPA108_2","FK506-BINDING PROTEIN;FRAP","5c65","SOLUTE CARRIER FAMILY 2, FACILITATED GLUCOSE TRANSPORTER MEMBER 3","Homo sapiens",4,"SER A 146;ARG A 151;PHE A 154;GLY A 152","None","0.87A","1fapB-5c65A:2.1","1fapB-5c65A:11.04"],["1FBM_B_RTLB951_0","PROTEIN (CARTILAGE OLIGOMERIC MATRIX PROTEIN)","5c65","SOLUTE CARRIER FAMILY 2, FACILITATED GLUCOSE TRANSPORTER MEMBER 3","Homo sapiens",4,"THR A 156;LEU A 160;LEU A 167;GLN A 170","None","1.03A","1fbmA-5c65A:undetectable","1fbmA-5c65A:7.43"],["1MZ9_D_VDYD1001_4","CARTILAGE OLIGOMERIC MATRIX PROTEIN","5c65","SOLUTE CARRIER FAMILY 2, FACILITATED GLUCOSE TRANSPORTER MEMBER 3","Homo sapiens",4,"THR A 156;LEU A 160;VAL A 163;LEU A 167","None","0.73A","1mz9D-5c65A:undetectable","1mz9D-5c65A:7.14"],["1Y0X_X_T44X500_1","THYROID HORMONE RECEPTOR BETA-1","5c65","SOLUTE CARRIER FAMILY 2, FACILITATED GLUCOSE TRANSPORTER MEMBER 3","Homo sapiens",5,"ILE A  14;ALA A  17;LEU A 229;ILE A 225;PHE A 154","None","1.26A","1y0xX-5c65A:undetectable","1y0xX-5c65A:20.47"],["2J7X_A_ESTA1454_1","ESTROGEN RECEPTOR BETA","5c65","SOLUTE CARRIER FAMILY 2, FACILITATED GLUCOSE TRANSPORTER MEMBER 3","Homo sapiens",5,"LEU A 276;LEU A 339;ILE A 285;GLY A 284;LEU A 282","None","1.24A","2j7xA-5c65A:undetectable","2j7xA-5c65A:21.11"],["2J9D_J_ACTJ1116_0","HYPOTHETICAL NITROGEN REGULATORY PII-LIKE PROTEIN MJ0059","5c65","SOLUTE CARRIER FAMILY 2, FACILITATED GLUCOSE TRANSPORTER MEMBER 3","Homo sapiens",4,"GLU A 391;ILE A 388;ILE A 384;GLU A 452","None","0.90A","2j9dJ-5c65A:undetectable;2j9dK-5c65A:undetectable;2j9dL-5c65A:undetectable","2j9dJ-5c65A:13.51;2j9dK-5c65A:13.51;2j9dL-5c65A:13.51"],["2NYR_B_SVRB401_2","NAD-DEPENDENT DEACETYLASE SIRTUIN-5;NAD-DEPENDENT DEACETYLASE SIRTUIN-5","5c65","SOLUTE CARRIER FAMILY 2, FACILITATED GLUCOSE TRANSPORTER MEMBER 3","Homo sapiens",4,"PHE A 414;GLN A 281;ASN A 409;LEU A 439","None","1.26A","2nyrA-5c65A:undetectable","2nyrA-5c65A:21.51"],["2P2F_A_ACTA653_0","ACETYL-COENZYME A SYNTHETASE","5c65","SOLUTE CARRIER FAMILY 2, FACILITATED GLUCOSE TRANSPORTER MEMBER 3","Homo sapiens",4,"VAL A 320;THR A 319;VAL A 163;GLY A 161","None","1.00A","2p2fA-5c65A:undetectable","2p2fA-5c65A:22.05"],["2P2F_B_ACTB653_0","ACETYL-COENZYME A SYNTHETASE","5c65","SOLUTE CARRIER FAMILY 2, FACILITATED GLUCOSE TRANSPORTER MEMBER 3","Homo sapiens",4,"VAL A 320;THR A 319;VAL A 163;GLY A 161","None","0.98A","2p2fB-5c65A:undetectable","2p2fB-5c65A:22.05"],["2W3B_B_FOLB401_1","DIHYDROFOLATE REDUCTASE","5c65","SOLUTE CARRIER FAMILY 2, FACILITATED GLUCOSE TRANSPORTER MEMBER 3","Homo sapiens",3,"GLU A 252;GLN A 395;ARG A 398","None","0.97A","2w3bB-5c65A:undetectable","2w3bB-5c65A:16.88"],["2XCT_X_CPFX1020_1","DNA GYRASE SUBUNIT B, DNA GYRASE SUBUNIT A;DNA GYRASE SUBUNIT B, DNA GYRASE SUBUNIT A","5c65","SOLUTE CARRIER FAMILY 2, FACILITATED GLUCOSE TRANSPORTER MEMBER 3","Homo sapiens",4,"ARG A 248;GLY A 396;GLU A 252;SER A 208","None","1.11A","2xctS-5c65A:undetectable;2xctU-5c65A:undetectable","2xctS-5c65A:20.58;2xctU-5c65A:20.58"],["2XRH_A_NIOA200_1","PROTEIN HP0721","5c65","SOLUTE CARRIER FAMILY 2, FACILITATED GLUCOSE TRANSPORTER MEMBER 3","Homo sapiens",4,"GLY A 161;ILE A 166;THR A  28;GLN A 159","None","0.98A","2xrhA-5c65A:undetectable","2xrhA-5c65A:10.71"],["3AG2_W_CHDW1059_0","CYTOCHROME C OXIDASE POLYPEPTIDE 7A1;CYTOCHROME C OXIDASE SUBUNIT 1","5c65","SOLUTE CARRIER FAMILY 2, FACILITATED GLUCOSE TRANSPORTER MEMBER 3","Homo sapiens",4,"ILE A 388;PHE A 387;ARG A 454;THR A 333","None","0.98A","3ag2N-5c65A:undetectable;3ag2W-5c65A:undetectable","3ag2N-5c65A:24.43;3ag2W-5c65A:9.59"],["3AG4_W_CHDW1059_0","CYTOCHROME C OXIDASE POLYPEPTIDE 7A1;CYTOCHROME C OXIDASE SUBUNIT 1","5c65","SOLUTE CARRIER FAMILY 2, FACILITATED GLUCOSE TRANSPORTER MEMBER 3","Homo sapiens",4,"ILE A 388;PHE A 387;ARG A 454;THR A 333","None","0.95A","3ag4N-5c65A:undetectable;3ag4W-5c65A:undetectable","3ag4N-5c65A:24.43;3ag4W-5c65A:9.59"],["3BOG_D_DVAD47_0","6.5 KDA GLYCINE-RICH ANTIFREEZE PROTEIN","5c65","SOLUTE CARRIER FAMILY 2, FACILITATED GLUCOSE TRANSPORTER MEMBER 3","Homo sapiens",4,"GLY A  77;GLY A  74;GLY A 128;GLY A 132","None","0.64A","3bogD-5c65A:undetectable","3bogD-5c65A:undetectable"],["3DH0_A_SAMA220_0","SAM DEPENDENT METHYLTRANSFERASE","5c65","SOLUTE CARRIER FAMILY 2, FACILITATED GLUCOSE TRANSPORTER MEMBER 3","Homo sapiens",5,"LEU A 133;VAL A  72;GLY A  73;GLY A  77;PHE A 130","None","1.36A","3dh0A-5c65A:undetectable","3dh0A-5c65A:17.61"],["3RQW_C_ACHC323_0","ELIC PENTAMERIC LIGAND GATED ION CHANNEL FROM ERWINIA CHRYSANTHEMI","5c65","SOLUTE CARRIER FAMILY 2, FACILITATED GLUCOSE TRANSPORTER MEMBER 3","Homo sapiens",4,"PHE A 393;GLU A 252;TYR A 266;LEU A 260","None","0.95A","3rqwC-5c65A:1.7;3rqwD-5c65A:1.7","3rqwC-5c65A:21.57;3rqwD-5c65A:21.57"],["3RQW_I_ACHI323_0","ELIC PENTAMERIC LIGAND GATED ION CHANNEL FROM ERWINIA CHRYSANTHEMI","5c65","SOLUTE CARRIER FAMILY 2, FACILITATED GLUCOSE TRANSPORTER MEMBER 3","Homo sapiens",4,"PHE A 393;GLU A 252;TYR A 266;LEU A 260","None","0.97A","3rqwI-5c65A:undetectable;3rqwJ-5c65A:undetectable","3rqwI-5c65A:21.57;3rqwJ-5c65A:21.57"],["3RQW_J_ACHJ323_0","ELIC PENTAMERIC LIGAND GATED ION CHANNEL FROM ERWINIA CHRYSANTHEMI","5c65","SOLUTE CARRIER FAMILY 2, FACILITATED GLUCOSE TRANSPORTER MEMBER 3","Homo sapiens",4,"GLU A 252;TYR A 266;LEU A 260;PHE A 393","None","1.01A","3rqwF-5c65A:undetectable;3rqwJ-5c65A:undetectable","3rqwF-5c65A:21.57;3rqwJ-5c65A:21.57"],["4FR0_A_SAMA401_0","ARSENIC METHYLTRANSFERASE","5c65","SOLUTE CARRIER FAMILY 2, FACILITATED GLUCOSE TRANSPORTER MEMBER 3","Homo sapiens",5,"GLY A 152;GLY A 155;GLU A 452;VAL A 326;LEU A 334","None","1.10A","4fr0A-5c65A:undetectable","4fr0A-5c65A:22.22"],["4J26_A_ESTA600_1","ESTROGEN RECEPTOR BETA","5c65","SOLUTE CARRIER FAMILY 2, FACILITATED GLUCOSE TRANSPORTER MEMBER 3","Homo sapiens",5,"LEU A 276;LEU A 339;ILE A 285;GLY A 284;LEU A 282","None","1.28A","4j26A-5c65A:undetectable","4j26A-5c65A:21.53"],["4OBW_B_SAMB601_0","2-METHOXY-6-POLYPRENYL-1,4-BENZOQUINOL METHYLASE, MITOCHONDRIAL","5c65","SOLUTE CARRIER FAMILY 2, FACILITATED GLUCOSE TRANSPORTER MEMBER 3","Homo sapiens",5,"ASN A 413;GLY A  73;GLY A  74;ILE A 127;GLY A 123","None","1.01A","4obwB-5c65A:undetectable","4obwB-5c65A:19.52"],["4Z3O_F_MFXF101_1","DNA TOPOISOMERASE 4 SUBUNIT B,PARE30-PARC55 FUSED TOPO IV FROM S. PNEUMONIAE;DNA TOPOISOMERASE 4 SUBUNIT B,PARE30-PARC55 FUSED TOPO IV FROM S. PNEUMONIAE;E-SITE DNA","5c65","SOLUTE CARRIER FAMILY 2, FACILITATED GLUCOSE TRANSPORTER MEMBER 3","Homo sapiens",4,"ARG A 248;GLY A 396;GLU A 252;SER A 208","None","1.08A","4z3oA-5c65A:undetectable;4z3oB-5c65A:undetectable","4z3oA-5c65A:22.10;4z3oB-5c65A:22.10"],["5B1A_W_CHDW101_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","5c65","SOLUTE CARRIER FAMILY 2, FACILITATED GLUCOSE TRANSPORTER MEMBER 3","Homo sapiens",4,"ILE A 388;PHE A 387;ARG A 454;THR A 333","None","1.04A","5b1aN-5c65A:0.7;5b1aW-5c65A:undetectable","5b1aN-5c65A:24.43;5b1aW-5c65A:9.59"],["5B3S_W_CHDW101_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","5c65","SOLUTE CARRIER FAMILY 2, FACILITATED GLUCOSE TRANSPORTER MEMBER 3","Homo sapiens",4,"ILE A 388;PHE A 387;ARG A 454;THR A 333","None","0.91A","5b3sN-5c65A:0.3;5b3sW-5c65A:undetectable","5b3sN-5c65A:24.43;5b3sW-5c65A:9.59"],["5CDQ_E_MFXE2101_1","DNA GYRASE SUBUNIT A;DNA GYRASE SUBUNIT B,DNA GYRASE SUBUNIT B;DNA GYRASE SUBUNIT A","5c65","SOLUTE CARRIER FAMILY 2, FACILITATED GLUCOSE TRANSPORTER MEMBER 3","Homo sapiens",4,"SER A 208;ARG A 248;GLY A 396;GLU A 252","None","0.88A","5cdqA-5c65A:1.3;5cdqB-5c65A:undetectable;5cdqC-5c65A:1.3","5cdqA-5c65A:22.54;5cdqB-5c65A:16.77;5cdqC-5c65A:22.54"],["5CDQ_V_MFXV2101_1","DNA GYRASE SUBUNIT A;DNA GYRASE SUBUNIT B,DNA GYRASE SUBUNIT B;DNA GYRASE SUBUNIT A","5c65","SOLUTE CARRIER FAMILY 2, FACILITATED GLUCOSE TRANSPORTER MEMBER 3","Homo sapiens",4,"SER A 208;ARG A 248;GLY A 396;GLU A 252","None","0.89A","5cdqR-5c65A:1.3;5cdqS-5c65A:undetectable;5cdqT-5c65A:undetectable","5cdqR-5c65A:22.54;5cdqS-5c65A:16.77;5cdqT-5c65A:22.54"],["5EQB_A_1YNA602_1","LANOSTEROL 14-ALPHA DEMETHYLASE","5c65","SOLUTE CARRIER FAMILY 2, FACILITATED GLUCOSE TRANSPORTER MEMBER 3","Homo sapiens",5,"GLY A 380;PHE A  70;PHE A  24;GLY A 128;GLY A 132","None","0.92A","5eqbA-5c65A:undetectable","5eqbA-5c65A:23.21"],["5ODI_A_ACTA701_0","HETERODISULFIDE REDUCTASE, SUBUNIT A","5c65","SOLUTE CARRIER FAMILY 2, FACILITATED GLUCOSE TRANSPORTER MEMBER 3","Homo sapiens",3,"LYS A 217;LYS A 243;SER A 246","None","1.35A","5odiA-5c65A:undetectable","5odiA-5c65A:19.94"],["5XDX_W_CHDW101_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT VIIA-HEART","5c65","SOLUTE CARRIER FAMILY 2, FACILITATED GLUCOSE TRANSPORTER MEMBER 3","Homo sapiens",4,"ILE A 388;PHE A 387;ARG A 454;THR A 333","None","0.91A","5xdxN-5c65A:0.6;5xdxW-5c65A:undetectable","5xdxN-5c65A:24.43;5xdxW-5c65A:9.59"],["5Z84_W_CHDW101_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","5c65","SOLUTE CARRIER FAMILY 2, FACILITATED GLUCOSE TRANSPORTER MEMBER 3","Homo sapiens",4,"ILE A 388;PHE A 387;ARG A 454;THR A 333","None","0.93A","5z84N-5c65A:0.6;5z84W-5c65A:undetectable","5z84N-5c65A:24.43;5z84W-5c65A:9.59"],["6CDU_A_EY4A501_0","CHIMERIC ALPHA1GABAA RECEPTOR","5c65","SOLUTE CARRIER FAMILY 2, FACILITATED GLUCOSE TRANSPORTER MEMBER 3","Homo sapiens",4,"GLN A 277;VAL A 275;PRO A 385;THR A 441","None","1.47A","6cduA-5c65A:2.2;6cduB-5c65A:1.8","6cduA-5c65A:21.24;6cduB-5c65A:21.24"],["6CDU_I_EY4I500_0","CHIMERIC ALPHA1GABAA RECEPTOR","5c65","SOLUTE CARRIER FAMILY 2, FACILITATED GLUCOSE TRANSPORTER MEMBER 3","Homo sapiens",4,"GLN A 277;VAL A 275;PRO A 385;THR A 441","None","1.50A","6cduI-5c65A:1.8;6cduJ-5c65A:1.6","6cduI-5c65A:21.24;6cduJ-5c65A:21.24"]]